Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18


Evidence for a direct link between PAD4-mediated citrullination and the oxidative burst in human neutrophils.

Zhou Y, An LL, Chaerkady R, Mittereder N, Clarke L, Cohen TS, Chen B, Hess S, Sims GP, Mustelin T.

Sci Rep. 2018 Oct 15;8(1):15228. doi: 10.1038/s41598-018-33385-z.


T follicular helper-like cells contribute to skin fibrosis.

Taylor DK, Mittereder N, Kuta E, Delaney T, Burwell T, Dacosta K, Zhao W, Cheng LI, Brown C, Boutrin A, Guo X, White WI, Zhu J, Dong H, Bowen MA, Lin J, Gao C, Yu L, Ramaswamy M, Gaudreau MC, Woods R, Herbst R, Carlesso G.

Sci Transl Med. 2018 Mar 7;10(431). pii: eaaf5307. doi: 10.1126/scitranslmed.aaf5307.


Perspective on Protein Arginine Deiminase Activity-Bicarbonate Is a pH-Independent Regulator of Citrullination.

Zhou Y, Mittereder N, Sims GP.

Front Immunol. 2018 Jan 18;9:34. doi: 10.3389/fimmu.2018.00034. eCollection 2018.


Spontaneous Secretion of the Citrullination Enzyme PAD2 and Cell Surface Exposure of PAD4 by Neutrophils.

Zhou Y, Chen B, Mittereder N, Chaerkady R, Strain M, An LL, Rahman S, Ma W, Low CP, Chan D, Neal F, Bingham CO 3rd, Sampson K, Darrah E, Siegel RM, Hasni S, Andrade F, Vousden KA, Mustelin T, Sims GP.

Front Immunol. 2017 Sep 25;8:1200. doi: 10.3389/fimmu.2017.01200. eCollection 2017.


Follicular Dendritic Cell Activation by TLR Ligands Promotes Autoreactive B Cell Responses.

Das A, Heesters BA, Bialas A, O'Flynn J, Rifkin IR, Ochando J, Mittereder N, Carlesso G, Herbst R, Carroll MC.

Immunity. 2017 Jan 17;46(1):106-119. doi: 10.1016/j.immuni.2016.12.014.


Loss of Immune Tolerance Is Controlled by ICOS in Sle1 Mice.

Mittereder N, Kuta E, Bhat G, Dacosta K, Cheng LI, Herbst R, Carlesso G.

J Immunol. 2016 Jul 15;197(2):491-503. doi: 10.4049/jimmunol.1502241. Epub 2016 Jun 13.


Characterization of the Hypercitrullination Reaction in Human Neutrophils and Other Leukocytes.

Zhou Y, Di Pucchio T, Sims GP, Mittereder N, Mustelin T.

Mediators Inflamm. 2015;2015:236451. doi: 10.1155/2015/236451. Epub 2015 May 19.


A glycoengineered anti-CD19 antibody with potent antibody-dependent cellular cytotoxicity activity in vitro and lymphoma growth inhibition in vivo.

Ward E, Mittereder N, Kuta E, Sims GP, Bowen MA, Dall'Acqua W, Tedder T, Kiener P, Coyle AJ, Wu H, Jallal B, Herbst R.

Br J Haematol. 2011 Nov;155(4):426-37. doi: 10.1111/j.1365-2141.2011.08857.x. Epub 2011 Sep 9.


B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody.

Herbst R, Wang Y, Gallagher S, Mittereder N, Kuta E, Damschroder M, Woods R, Rowe DC, Cheng L, Cook K, Evans K, Sims GP, Pfarr DS, Bowen MA, Dall'Acqua W, Shlomchik M, Tedder TF, Kiener P, Jallal B, Wu H, Coyle AJ.

J Pharmacol Exp Ther. 2010 Oct;335(1):213-22. doi: 10.1124/jpet.110.168062. Epub 2010 Jul 6. Erratum in: J Pharmacol Exp Ther. 2011 Jan;336(1):294. Dall'Aqua, William [corrected to Dall'Acqua, William].


Gene therapy vector-mediated expression of insulin-like growth factors protects cardiomyocytes from apoptosis and enhances neovascularization.

Su EJ, Cioffi CL, Stefansson S, Mittereder N, Garay M, Hreniuk D, Liau G.

Am J Physiol Heart Circ Physiol. 2003 Apr;284(4):H1429-40. Epub 2002 Dec 27.


Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation.

Ancellin N, Colmont C, Su J, Li Q, Mittereder N, Chae SS, Stefansson S, Liau G, Hla T.

J Biol Chem. 2002 Feb 22;277(8):6667-75. Epub 2001 Dec 10.


Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy.

Mittereder N, March KL, Trapnell BC.

J Virol. 1996 Nov;70(11):7498-509.


Transduction of normal and malignant oral epithelium by an adenovirus vector: the effect of dose and treatment time on transduction efficiency and tissue penetration.

Clayman GL, Trapnell BC, Mittereder N, Liu TJ, Eicher S, Zhang S, Shillitoe EJ.

Cancer Gene Ther. 1995 Jun;2(2):105-11.


In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung.

Yei S, Mittereder N, Wert S, Whitsett JA, Wilmott RW, Trapnell BC.

Hum Gene Ther. 1994 Jun;5(6):731-44.


Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA.

Mittereder N, Yei S, Bachurski C, Cuppoletti J, Whitsett JA, Tolstoshev P, Trapnell BC.

Hum Gene Ther. 1994 Jun;5(6):717-29.


Adenovirus-mediated gene transfer for cystic fibrosis: quantitative evaluation of repeated in vivo vector administration to the lung.

Yei S, Mittereder N, Tang K, O'Sullivan C, Trapnell BC.

Gene Ther. 1994 May;1(3):192-200.


Factors affecting retroviral vector function and structural integrity.

McLachlin JR, Mittereder N, Daucher MB, Kadan M, Eglitis MA.

Virology. 1993 Jul;195(1):1-5.


A human rel proto-oncogene cDNA containing an Alu fragment as a potential coding exon.

Brownell E, Mittereder N, Rice NR.

Oncogene. 1989 Jul;4(7):935-42.


Supplemental Content

Loading ...
Support Center